Picture of Fennec Pharmaceuticals logo

FENC — Fennec Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapHigh Flyer

Brief: Fennec Pharmaceuticals Announces Commercial Availability Of Pedmark (Sodium Thiosulfate Injection) In The U.S.

Oct 17 (Reuters) - Fennec Pharmaceuticals Inc  FENC.O :
    * FENNEC PHARMACEUTICALS ANNOUNCES COMMERCIAL AVAILABILITY
OF
PEDMARK® (SODIUM THIOSULFATE INJECTION) IN THE UNITED STATES

Source text for Eikon:  ID:nGNX1pn76h 
Further company coverage:  FENC.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Fennec Pharmaceuticals

See all news